These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23658743)

  • 1. Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival.
    Fang Y; Wei J; Cao J; Zhao H; Liao B; Qiu S; Wang D; Luo J; Chen W
    PLoS One; 2013; 8(5):e62558. PubMed ID: 23658743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells.
    Dai YH; Tang YP; Zhu HY; Lv L; Chu Y; Zhou YQ; Huo JR
    Dig Dis Sci; 2012 May; 57(5):1253-60. PubMed ID: 22350782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
    Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition associated markers in sarcomatoid transformation of clear cell renal cell carcinoma.
    Čugura T; Boštjančič E; Uhan S; Hauptman N; Jeruc J
    Exp Mol Pathol; 2024 Aug; 138():104909. PubMed ID: 38876079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma.
    Qi S; Song Y; Peng Y; Wang H; Long H; Yu X; Li Z; Fang L; Wu A; Luo W; Zhen Y; Zhou Y; Chen Y; Mai C; Liu Z; Fang W
    PLoS One; 2012; 7(6):e38842. PubMed ID: 22761708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma.
    Cai MY; Luo RZ; Chen JW; Pei XQ; Lu JB; Hou JH; Yun JP
    PLoS One; 2012; 7(2):e32838. PubMed ID: 22393452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of epithelial-mesenchymal transition in localized, surgically treated clear-cell renal cell carcinoma.
    Gasinska A; Jaszczynski J; Adamczyk A; Janecka-Widła A; Wilk W; Cichocka A; Stelmach A
    Folia Histochem Cytobiol; 2018; 56(4):195-206. PubMed ID: 30569446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
    Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
    Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.
    White NM; Khella HW; Grigull J; Adzovic S; Youssef YM; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Jewett MA; Evans AJ; Gabril M; Yousef GM
    Br J Cancer; 2011 Nov; 105(11):1741-9. PubMed ID: 22033272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition.
    Han X; Piao L; Yuan X; Wang L; Liu Z; He X
    Int J Med Sci; 2019; 16(10):1404-1411. PubMed ID: 31692936
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma.
    Han KS; Li N; Raven PA; Fazli L; Ettinger S; Hong SJ; Gleave ME; So AI
    Mol Cancer Ther; 2015 Apr; 14(4):1024-34. PubMed ID: 25657336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-206 inhibits proliferation of renal clear cell carcinoma by targeting ZEB2.
    Chen XF; Guo JF; Xu JF; Yin SH; Cao WL
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7826-7834. PubMed ID: 31599407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma.
    Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T
    BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
    Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
    J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
    Harada K; Miyake H; Kusuda Y; Fujisawa M
    BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer.
    Prislei S; Martinelli E; Zannoni GF; Petrillo M; Filippetti F; Mariani M; Mozzetti S; Raspaglio G; Scambia G; Ferlini C
    Oncotarget; 2015 Aug; 6(22):18966-79. PubMed ID: 26136338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
    Filipović J; Bosić M; Ćirović S; Životić M; Dunđerović D; Đorđević D; Živković-Perišić S; Lipkovski A; Marković-Lipkovski J
    Diagn Pathol; 2019 Oct; 14(1):120. PubMed ID: 31655611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
    Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
    Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
    Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
    Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.